AVITA Medical, Inc. (NASDAQ:RCEL) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT
Company Participants
James Corbett – CEO, President & Executive Director
Presentation
Unknown Analyst
Okay. Thank you, everybody, for joining us. This is Morgan Stanley’s 23rd Global Healthcare Conference, and we’re excited to bring interesting stories to you all.
Before we get started today, there’s going to be an important disclosure available on our research website. So if you go to www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to a Morgan Stanley representative. And with that out of our way, I’d like to turn it over to Jim to first introduce yourself and then let’s start talking about AVITA, which is a very exciting and interesting company that I’ve had the pleasure of getting to know over the last few years. And this conversation will help, I think, level set the story where you are today and where you guys are headed.
James Corbett
CEO, President & Executive Director
Perfect. My name is Jim Corbett, and I’m CEO of AVITA Medical. We have a really exciting therapeutic acute wound care portfolio, which is headlined by a technology called RECELL, which I’m sure we’ll talk about here in a moment.
Question-and-Answer Session
Unknown Analyst
Awesome. So maybe just to dive in, can you tell us how — what is the RECELL platform itself? And how does that fit into the overall mission of AVITA?
James Corbett
CEO, President & Executive Director
Well, RECELL is really unique. And in a way, I’m going to describe it at the end. What it produces is a spray on skin graft. And when you think about that conceptually, it’s like how does that happen? Well, what we do is we take a very small autologous from the patient biopsy, and we disaggregate it in
Credit: Source link
